Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Abstract LB-310: Effects of epidermal growth factor receptor (EGFR) expression on anti-tumor efficacy of vandetanib or cediranib combined with radiotherapy (RT) in U87 human glioblastoma (GBM) xenografts, Cancer Research, April 2010, American Association for Cancer Research (AACR),
DOI: 10.1158/1538-7445.am10-lb-310.
You can read the full text:
Contributors
The following have contributed to this page
